Even as the world’s largest medical device companies grapple with COVID-19 and the resulting recession, they’re doing important work to help humanity manage the crisis. Read on to find out more about the 10 largest companies in the Big 100, MassDevice and Medical Design & Outsourcing’s annual analysis of the worlds’ 100 largest medical device companies. […]
MassDevice Big 100
The 20 largest medical device companies in the world
The information in this year’s annual Big 100 rankings of the world’s largest medical device companies is as interesting as ever. The 100 companies on this year’s list had medical device businesses bringing in a whopping $420.5 billion during their most recent fiscal years — a nearly 6% increase from the 2019 Big 100. But […]
The 10 largest medtech employers – and what their workers really think
Among the 10 largest medtech employers, workers feel pride in working on life-saving products – but there’s also frustration with big corporate bureaucracy. That was the major takeaway as Medical Design & Outsourcing compiled some of the most insightful current and former employee reviews posted on Glassdoor. The 10 companies we’re counting down were the largest […]
Big 100 West: Compliance, competition and the cash incentive
Compliance concerns may be driven largely by the desire to say out of the regulatory spotlight, but it’s also a business strategy, a panel of experts told an audience during this week’s MassDevice.com Big 100 West event in Orange County, Calif.
Big 100 West: Engineering, naivety and the birth of Second Sight’s ‘bionic eye’
ResMed’s Mick Farrell: “Our primary competitor is ignorance”
The story behind ResMed‘s (NYSE:RMD) meteoric rise from Baxter spinout to $1.5 billion medical device Goliath is no snore.
Or maybe it is. After all, stopping snoring has paid off pretty nicely for the San Diego-based sleep apnea device company, which has a more than 40% share in the growing market for products to diagnose, treat and manage respiratory disorders.
Can Glooko disrupt the way diabetes is managed?
Glooko continues to carve out a niche in the mobile diabetes management space.
News makers and game changers at the MassDevice Big 100 East 2013
Photograph by Carolyn Bick
Nearly 300 of the industry’s best and brightest gathered for a night of big ideas, industry insights and few cocktails last night at MassDevice.com’s Big 100 East 2013 conference in Waltham, Mass.
Medtech CEO Amar Sawhney named among White House’s Champions of Change
Amar Sawhney at a meet-and-greet outside of President Barack Obama’s Chicago home.
Podcast: Boston Scientific CEO Michael Mahoney at the MassDevice Big 100 East
Click to play podcast
Maybe the only mistake Boston Scientific (NYSE:BSX) made when they hired Michael Mahoney as CEO was waiting so long to do it.
After spending much of the last half of a decade in a turnaround that never seemed to get off the ground, the medical device goliath seems to be on the up and up.
Japan tops Q1 growth estimates
A key market for the medical device industry showed some strong signs of life today, following sobering economic news out of Europe yesterday.
Japan, the world’s 3rd-largest economy and 2nd-largest medical device market, reported that its gross domestic product grew at an annualized rate of 3.5% during the 1st quarter and is up 0.9% from the previous quarter. Analysts had predicted a 2.8% annualized growth rate and 0.7% growth for the quarter.
